Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease

Histology and Histopathology

Volumn 12, Issue 1, 1997, Pages 99-109

  Vinores, S A ^a   Youssri, A I ^a   Luna, J D ^a   Chen, Y S ^a   Bhargave, S ^a   Vinores, M A ^a   Schoenfeld, C L ^a   Peng, B ^b   Chan, Ch Ch ^b   LaRochelle, W ^c   Green, W R ^a   Campochiaro, P A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

blood retinal barrier; experimental autoimmune uveoretinitis; ischemia; macular edema; vascular endothelial growth factor

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BLOOD RETINA BARRIER; CONTROLLED STUDY; DIABETIC RETINOPATHY; ETIOLOGY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; RAT; RETINA BLOOD VESSEL OCCLUSION; RETINA ISCHEMIA; RETINA MACULA EDEMA; UVEORETINITIS;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD-RETINAL BARRIER; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LYMPHOKINES; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RETINAL DISEASES; RETINAL VESSELS; RETINITIS; UP-REGULATION; UVEITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; CYSTOIDEA;

EID: 0031038075     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Adamis A.P., Shima D.T., Yeo K.-T., Yeo T.-K., Brown L.F., Berse B., D'Amore P.A. and Folkman J. (1993). Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 193, 631-638.
2. Adamis A.P., Miller J.W., Bernal M.-T., D'Amico D.J., Folkman J., Yeo T.-K. and Yeo K.-T. (1994). Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118, 445-450.
3. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H.V., Aiello L.M., Ferrara N. and King G.L. (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480-1487.
4. Aiello L.P., Pierce E.A., Foley E.D., Sullivan R., Chen H., Ferrara N., King G.L. and Smith L.E.H. (1995). Inhibition of vascular endothelial growth factor (VEGF) reduces retinal neovascularization in the mouse. Invest. Opthalmol. Vis. Sci. 36, S401.
5. Barthel L.K. and Raymond P.A. (1990). Improved method for obtaining 3-μm cryosections for immunocytochemistry. J. Histochem. Cytochem. 38, 1383-1388.